6 recruiting, 5 completed, 2 not yet recruiting, 2 unknown. 5 Not applicable, 4 Phase 2, 2 Early Phase 1, 2 Phase 1, 1 Phase 3.
Follow T1DM: new trials by email Literature Review of T1DM trials Research Report on T1DM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-Exercise Whey and Pea Protein in Adolescents With Type 1 Diabetes low whey protein, moderate whey protein, low Pea protein - T1D, T1DM | Not applicable | Not yet recruiting | University of Jordan | 30 | 2026-10-01 | 2026-09-23 |
| A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar Tirzepatide, Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM), Carbohydrate Counting - Type 1 Diabetes, Type 1 Diabetes Mellitus | Phase 2 / Phase 3 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 105 | 2026-05-19 | 2026-05-27 |
| Simultaneous Measurement and Responsive Treatment - Part 2 DPP System (Insulin Pump and Continuous Glucose Monitoring Platform) - Type 1 Diabetes Mellitus, T1D | Early Phase 1 | Recruiting | ClinSurge Research | 40 | 2026-05-19 | 2026-06-23 |
| Pediatric Insulin Plan Calculator for T1DM Management Flexible Digital Insulin Dose Calculator - Type 1 Diabetes Mellitus, Type 1 Diabetes Mellitus (T1DM) | Not applicable | Recruiting | Sultan Qaboos University | 440 | 2026-05-03 | 2026-06-09 |
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Recruiting | Otsuka Pharmaceutical Factory, Inc. | 13 | 2025-06-10 | 2026-08-21 |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) CNP-103, Placebo - Type 1 Diabetes Mellitus, T1D | Phase 1 / Phase 2 | Recruiting | COUR Pharmaceutical Development Company, Inc. | 72 | 2025-05-12 | 2026-09-11 |
| Influence of Circadian Clock on Hormonal, Metabolic, Neurocognitive Markers in Adolescents With and Without Diabetes Reversed Circadian Rhythm, Normal Circadian Rhythm - T1DM, Sleep Disorders, Circadian Rhythm | Not yet recruiting | Assaf-Harofeh Medical Center | 100 | 2022-01-01 | 2020-05-26 | |
| RCT for Evaluation of Insulin Administration,While Using the iPORT System I-port use - T1DM | Not applicable | Unknown | Assaf-Harofeh Medical Center | 35 | 2020-10-01 | 2020-06-09 |
| Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus Hyperbaric oxygen chamber (HBOC) - T1DM | Not applicable | Unknown | Assaf-Harofeh Medical Center | 36 | 2020-06-01 | 2022-09-21 |
| Glycemic Control and Quality of Life With i- Port Advance in Pediatric T1DM I-Port Advance use - T1DM | Not applicable | Withdrawn | Assaf-Harofeh Medical Center | 2020-05-01 | 2022-08-10 | |
| Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps) Health related quality of life - T1DM, Health Related Quality of Life | Completed | Ain Shams University | 60 | 2020-03-15 | 2021-02-23 | |
| Brain Health and Development With T1DM T1DM, Brain Development | Completed | Washington University School of Medicine | 290 | 2016-09-01 | 2024-04-11 | |
| Type 1 Diabetes Extension Study Type 1 Diabetes Mellitus, T1DM | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 111 | 2016-06-08 | 2026-09-18 | |
| The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series Fluticasone Propionate - T1DM, Hypersensitivity | Early Phase 1 | Completed | Assaf-Harofeh Medical Center | 13 | 2016-03-01 | 2019-08-13 |
| Glycemic Control and Treatment Satisfaction in Children With Type 1 Diabetes Using Insulin Pumps T1DM | Completed | Assaf-Harofeh Medical Center | 60 | 2015-05-31 | 2018-10-05 | |
| Tocilizumab (TCZ) in New-onset Type 1 Diabetes Tocilizumab (TCZ), Placebo, Standard of Care - Type 1 Diabetes Mellitus, New-onset Type 1 Diabetes Mellitus | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 136 | 2015-03-12 | 2021-09-08 |
Diabetes Mellitus, Type 1 (8) · Autoimmune Diseases (2) · Diabetes Mellitus (2) · Attention Deficit Disorder with Hyperactivity (1) · Glucose Intolerance (1) · Glucose Metabolism Disorders (1) · Hypersensitivity (1) · Hypoglycemia (1) · Immune System Diseases (1) · Inflammation (1) · Insulin Resistance (1) · Memory Disorders (1) · Metabolic Diseases (1) · Overweight (1) · Sleep Disorders, Circadian Rhythm (1)
Endocrine System Diseases (8) · Immune System Diseases (8) · Nutritional and Metabolic Diseases (8) · Glucose Metabolism Disorders (7) · Metabolic Diseases (7) · Autoimmune Diseases (6) · Diabetes Mellitus (6) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Body Weight (1) · Chronobiology Disorders (1) · Dyssomnias (1) · Hyperglycemia (1) · Hyperinsulinism (1)
Fluticasone (1) · Quality of Life (1) · Standard of Care (1) · Therapeutics (1) · Tirzepatide (1) · tocilizumab (1)
Assaf-Harofeh Medical Center (6) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Ain Shams University (1) · COUR Pharmaceutical Development Company, Inc. (1) · ClinSurge Research (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Otsuka Pharmaceutical Factory, Inc. (1) · Sultan Qaboos University (1) · University of Jordan (1) · Washington University School of Medicine (1)
United States (5) · Canada (2) · Australia (1) · Egypt (1) · Iraq (1) · Israel (1) · Pakistan (1) · Switzerland (1)
Ahmad Haidar, PhD (1) · Avital Leshem (1) · Carla Greenbaum (1) · Jane Buckner, M.D. (1) · Linda A. DiMeglio, MD, MPH,MA (1) · Melissa-Rosina Pasqua, MD, PhD (1) · Paul Peloso, MD (1) · Tamara G Hershey, PhD (1)